drugset / Trial / NCT03826316

Pharmacokinetics of Nalbuphine Injection

NCT03826316

NaSingle-groupOpen-labelTreatment

Summary

A study to evaluate pharmacokinetics of nalbuphine hydrochloride (10 mg/mL) after a single intravenous administration in healthy volunteers under fasting conditions

Timeline

Start
2018-01-15
Primary completion
2018-11-22
Completion
2019-01-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Nalbuphine Small molecule 10 mg/ml Intravenous

Indications